Phenylephrine HydrochlorideThird Party Manufacturing in India

Phenylephrine Hydrochloride works by selectively binding to alpha-1 adrenergic receptors on the smooth muscle of conjunctival and pupillary dilator blood vessels. It stimulates these receptors to cause rapid vasoconstriction and contraction of the pupillary dilator muscle, leading to marked mydriasis. Unlike non-selective sympathomimetics, it does not significantly trigger beta-adrenergic receptors, minimizing adverse cardiovascular parameters like tachycardia during localized ocular application. It provides clean, controlled pupillary dilation without inducing cycloplegia, ensuring the patient maintains normal accommodative focus. It is highly effective and well-tolerated.

Therapeutic Uses

• Pupillary Dilation: Facilitates thorough fundus examinations, ophthalmoscopy, and diagnostic procedures in clinical setups.
• Uveitis Management: Aids in breaking or preventing posterior synechiae formation in patients experiencing active uveitis.
• Ocular Decongestion: Alleviates minor redness and conjunctival vascular congestion triggered by irritation.

Why Manufacturers Choose Phenylephrine Hydrochloride

Phenylephrine ophthalmic solutions remain indispensable diagnostic reagents across global optometry and ophthalmology networks. Our partner production facilities enforce cleanroom environments and precise chemical synthesis methods compliant with WHO-GMP parameters to prevent any degradation of active chemical compounds matching CAS number 61-76-7. Outsourcing Phenylephrine Hydrochloride third party manufacturing in India through Celesta ensures a continuous, scalable supply of high-purity formulations across standard clinical strengths.